22nd Annual Meeting of the Society of Urologic Oncology
December 1 - 3, 2021
JW Marriott Orlando Grande Lakes
Orlando, Florida
摘要：
The final date for abstract submission is August 2, 2021.There will be no extension to the submission deadline. Abstracts may be submitted only through the website. Any other method will not be considered. Please read the abstact submission guidelines and the trial-in-progress submission guidelines before submitting your abstract.
Notifications of acceptance/rejections will be sent to all entrants in September 2021. Please note this schedule is subject to change. This year, all posters will be presented electronically. Further instructions regarding presentations will be distributed upon acceptance.
Note: you will be required to complete a CME disclosure form for every abstract you submit.
Industry Employee whose company is already supporting SUO OR Industry Medical Science Liaison
$500
Industry Employee whose company is NOT already supporting SUO
$2500
Encore Registration
Encore registration is being offered to attendees who are unable to travel to the meeting. Presentations will be recorded and posted on the virtual meeting platform the week after the meeting. CME credit will be available to Encore Registrants. In-person attendees will also have access to the platform.
Registration Categories
Regular Fees
after 11/15/2021
Member
$200
Senior Member
$90
Nonmember Urologist
$300
Nonphysician Provider
$90
Student
$90
Resident
$90
Fellow
$90
SUO Symposium on Clinical Research & Clinical Trials Registration
WEDNESDAY, DECEMBER 1, 2021, 8:00AM – 12:00PM
Registration Categories
Early Discounted
through 11/15/2021
Regular Fees
after 11/15/2021
Member
$200
$250
SUO CTC Member
$150
$200
Nonmember Urologist
$300
$350
Nonphysician Provider
$100
$125
Student
$0
$0
Resident
$0
$0
Fellow
$0
$0
SUO Bladder Cancer Course
TUESDAY, NOVEMBER 30, 2021
Registration Categories
Regular Fees
Member
$0
Student
$0
Resident
$0
Fellow
$0
Nonmember
$100
YUO Dinner
WEDNESDAY, DECEMBER 1, 2021
NOTE: YUO membership is limited to current fellows, residents, and medical students, and urologists who completed their fellowship in 2014 or later, or completed their residency in 2012 or later.
